The DEFA14A contains no new financial or strategic information — it is a routine employee communication. The stock should trade near the $14.00 deal price with a small spread reflecting regulatory and timing risk. Monitor for the definitive proxy statement and any shareholder litigation that could delay or alter terms.
Price Chart
Executive Summary
Organon filed this DEFA14A as additional soliciting material in support of its pending acquisition by Sun Pharma for $14.00 per share in cash. The document is an employee-focused Q&A that reiterates deal terms, including one-year compensation and benefits protections, and confirms the path to a shareholder vote and regulatory approvals. This is a routine communication that does not change the deal's terms or probability of closing.
Key Financial Metrics
Key Facts
- Sun Pharma to acquire Organon for $14.00 per share in cash, representing a 103% premium
- Enterprise value of $11.75 billion
- Deal announced April 26, 2026; definitive merger agreement signed same day
- Organon remains independent until closing; shareholder vote and regulatory approvals in more than a dozen countries required
- Pre-2026 RSUs will fully accelerate and be paid out in cash at $14.00 per unit at closing
- Post-2026 RSUs will convert to cash-based awards at $14.00 per unit and continue vesting on original schedule
- Sun Pharma commits to one year of base salary, bonus, benefits, and severance protections for continuing employees
- Prior service at Organon will be credited for vesting, benefit accrual, and eligibility at Sun Pharma
Financial Impact
Deal valued at $11.75 billion enterprise value; $14.00 per share cash consideration
Risk Factors
- Regulatory approvals in multiple jurisdictions may delay or block closing
- Shareholder vote required; failure to obtain minimum vote could scuttle deal
- Competing acquisition proposals could emerge
- Stockholder litigation could result in costs or injunctions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-194151 |
| Document: 0001193125-26-194151-index-headers.html | 0001193125-26-194151 |
| Document: 0001193125-26-194151-index.html | 0001193125-26-194151 |
| Document: 0001193125-26-194151.txt | 0001193125-26-194151 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 10w ago | Institutional Cluster | $13.68 | awaiting T+60 | — | $13.74 (−0.44%) |
Jul 31, 2026 12w ago | 8-K | $13.55 $13.74 | ▼ −1.40% | ▲ +1.05% | $13.74 (−1.40%) |
Jul 17, 2026 14w ago | 8-K | $13.49 $13.77 | ▲ +2.08% | ▼ −2.76% | $13.74 (+1.85%) |
Jun 17, 2026 18w ago | DEFM14A | $13.42 $13.64 | ▲ +1.64% | ▼ −1.51% | $13.74 (+2.38%) |
Jun 11, 2026 19w ago | DEFA14A | $13.45 $13.78 | ▲ +2.45% | ▼ −1.94% | $13.74 (+2.16%) |
Jun 1, 2026 21w ago | PREM14A | $13.37 $13.75 | ▲ +2.84% | ▲ +1.87% | $13.74 (+2.81%) |
Apr 30, 2026 25w ago | DEFA14A | $13.25 $13.52 | ▲ +2.08% | ▼ −0.74% | $13.74 (+3.74%) |
Apr 30, 2026 25w ago | 8-K | $13.25 $13.52 | ▼ −2.08% | ▲ +0.74% | $13.74 (−3.74%) |
Apr 27, 2026 26w ago | DEFA14A | $13.32 $13.56 | ▲ +1.84% | ▼ −1.88% | $13.74 (+3.19%) |
Apr 27, 2026 26w ago | DEFA14A | $13.32 $13.56 | ▲ +1.84% | ▼ −1.88% | $13.74 (+3.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers